Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3227-3233

  Shiratori, Tooru ^a   Shimada, Hideaki ^a   Kagaya, Akiko ^a   Kuboshima, Mari ^a   Nabeya, Yoshihiro ^a   Machida, Toshio ^a   Goto, Ken Ichiro ^a,b   Takiguchi, Masaki ^a   Ochiai, Takenori ^a   Hiwasa, Takaki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SHIMOSHIZU HOSPITAL   (Japan)

Author keywords

Esophageal squamous cell carcinoma; MTT assay; p53; SEREX; SUMO

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; COMPLEMENTARY DNA; ERBSTATIN; ETOPOSIDE; FORSKOLIN; MITOXANTRONE; NIMUSTINE; PER1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; RAN PROTEIN; REPLICATION PROTEIN A; RHO GUANINE DISSOCIATION INHIBITOR ALPHA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSKETOLASE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME 21; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CHEMOSENSITIVITY; COLORIMETRY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ESOPHAGUS CARCINOMA; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DNA, COMPLEMENTARY; ESOPHAGEAL NEOPLASMS; ETOPOSIDE; FIBROBLASTS; GENES, RAS; MICE; MITOXANTRONE; NIH 3T3 CELLS; TRANSFECTION; UBIQUITIN-CONJUGATING ENZYMES; VINCRISTINE;

EID: 35348986511     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Isono K and Ochiai T: Recent advances of treatment of cancer of the esophagus (review). Ann Cancer Res Ther 1: 9-16, 1992.
2. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813, 1995.
3. Cancer immunome database: http://www2.licr.org/CancerImmunomeDB/
4. Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, Matsubara H, Nomura F, Takiguchi M and Hiwasa T: Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 112: 1029-1035, 2004.
5. Shimada H, Nakashima K, Ochiai T, Nabeya Y, Takiguchi M, Nomura F and Hiwasa T: Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol 26: 77-86, 2005.
6. Kuboshima M, Shimada H, Liu TL, Nakashima K, Nomura F, Takiguchi M, Hiwasa T and Ochiai T: Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma. Int J Oncol 28: 463-468, 2006.
7. Kuboshima M, Shimada H, Liu TL, Nomura F, Takiguchi M, Hiwasa T and Ochiai T: Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci 97: 380-386, 2006.
8. Hiwasa T, Shimada H, Ochiai T and Takiguchi M: Serological identification of antigens by recombinant cDNA expression cloning (SEREX) using antibodies from patients with esophageal squamous cell carcinoma. In: Moleculomics and Thereafter. Hiwasa T (ed.). Kerala, India, Research Signpost, pp. 99-117, 2006.
9. Hiwasa T, Shimada H, Sakaida T, Kitagawa M, Kuroiwa N, Ochiai T and Takiguchi M: Drug-sensitivity pattern analysis of study of functional relationship between gene products. FEBS Lett 552: 177-183, 2003.
10. Hiwasa T: DSPA, a new method for comprehensive analysis of gene function. In: Moleculomics and Thereafter. Hiwasa T, (ed.). Kerala, India, Research Signpost, pp. 143-157, 2006.
11. Takahashi K, Kanazawa H, Chan H, Hosono T, Takahara M and Sato K: A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T.T. and T.Tn.). Jpn J Oral Maxillofac Surg 36: 307-316, 1990.
12. Shimada H, Shimizu T, Ochiai T, Liu TL, Sashiyama H, Nakamura A, Matsubara H, Gunji Y, Kobayashi S, Tagawa M, Sakiyama S and Hiwasa T: Preclinical study of adenoviral p53 gene therapy for esophageal cancer. Surg Today 31: 597-604, 2001.
13. Sekiya T, Fushimi M, Mori H, Hirohashi S, Nishimura S and Sugimura T: Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in melanoma from a Japanese patient. Proc Natl Acad Sci USA 81: 4771-4775, 1998.
14. Suzuki Y, Yoshitomo K, Maruyama K, Suyama A and Sugano S: Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library. Gene 200: 149-156, 1997.
15. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol Methods 65: 55-63, 1983.
16. Shimada H, Liu TL, Ochiai T, Shimizu T, Haupt Y, Hamada H, Abe T, Oka M, Takiguchi M and Hiwasa T: Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells. Oncogene 21: 1208-1216, 2002.
17. Liu TL, Shimada H, Ochiai T, Shiratori T, Lin S-E, Kitagawa M, Harigaya K, Maki M, Oka M, Abe T, Takiguchi M and Hiwasa T: Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-κB p65 in esophageal carcinoma cells: possible involvement of Fas/Fas-L synergism. Apoptosis 11: 1025-1037, 2006.
18. Wang ZY, Qiu QQ, Seufert W, Taguchi T, Testa JR, Whitmore SA, Callen DF, Welsh D, Shenk T and Deuel TF: Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9. J Biol Chem 271: 24811-24816, 1996.
19. Watanabe TK, Fujiwara T, Kawai A, Shimizu F, Takami S, Hirano H, Okuno S, Ozaki K, Takeda S, Shimada Y, Nagata M, Takaichi A Takahashi E, Nakamura Y and Shin S: Cloning, expression, and mapping of UBE2I, a novel gene encoding a human homologue of yeast ubiquitin-conjugating enzymes which are critical for regulating the cell cycle. Cytogenet Cell Genet 72: 86-89, 1996.
20. Yasugi T and Howley PM: Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9. Nucleic Acids Res 24: 2005-2010, 1996.
21. Shi Y, Zou M, Farid NR and Paterson MC: Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem J 352: 443-448, 2000.
22. Waite KA and Eng C: BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum Mol Genet 12: 679-684, 2003.
23. Chih D, Park D, Gross M, Idos G, Vuong P, Hirama T, Chumakov A, Said J and Koeffler H: Protein partners of C/EBPε. Exptl Hematol 32: 1173-1181, 2004.
24. Bernier-Villamor V, Sampson DA, Matunis MJ and Lima CD: Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108: 345-356, 2002.
25. Shen Z, Pardington-Purtymun PE, Comeaux JC, Moyzis RK and Chen DJ: Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system. Genomics 37: 183-186, 1996.
26. Sardana MK and Kappas A: Dual control mechanism for heme oxygenase: tin (IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci USA 84: 2464-2468, 1986.
27. Okada T, Sakuma L, Fukui Y, Hazeki O and Ui M: Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J Biol Chem 269: 3563-3567, 1994.
28. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M and Narumiya S: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
29. Bork PM, Schmitz ML, Kuhnt M, Escher C and Heinrich M: Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB. FEBS Lett 402: 85-90, 1997.
30. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T and Gerritsen ME: Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103, 1997.
31. Ueno H, Escobedo JA and Williams LT: Dominant-negative mutations of platelet-derived growth factor (PDGF) receptors. Inhibition of receptor function by ligand-dependent formation of heterodimers between PDGF α- and β-receptors. J Biol Chem 268: 22814-22819, 1993.
32. Wold MS: Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu Rev Biochem 66: 61-92, 1997.
33. Miller SD, Moses K, Jayaraman L and Prives C: Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single- stranded DNA. Mol Cell Biol 17: 2194-2201, 1997.
34. Abramova NA, Russell J, Botchan M and Li R: Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner. Proc Natl Acad Sci USA 94: 7186-7191, 1997.
35. Pray TR, Parlati F, Huang J, Wong BR, Payan DG, Bennett MK, Issakani SD, Molineaux S and Demo SD: Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat 5: 249-258, 2002.
36. Adams J: The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5: 417-421, 2004.